- Ginkgo Why Massachusetts and MassVentures🔍
- Congratulations Ginkgo Bioworks🔍
- Ginkgo Bioworks Secures $45 Million to Support Next Stage of Growth🔍
- Diverse Teams Outperform🔍
- In the news🔍
- Ginkgo Bioworks scraps Seaport expansion plans amid struggles🔍
- MassVentures Report Highlights START Success🔍
- 2021 START Winners Reshape the Present and Future of Life ...🔍
Ginkgo Why Massachusetts and MassVentures
Ginkgo Why Massachusetts and MassVentures - YouTube
Co founders of Ginkgo Bioworks, Jason Kelly and Reshma Shetty, discuss the importance of locating in Massachusetts and the benefits of ...
Congratulations Ginkgo Bioworks - MassVentures
Even though MassVentures is a small investor and was an early board observer, Ginkgo has been there for us to help ensure the success of our evergreen fund, our ...
Ginkgo Bioworks Secures $45 Million to Support Next Stage of Growth
Ginkgo Bioworks first received local funding from the MassVentures' START program which supports the commercialization of Massachusetts-based companies ...
Diverse Teams Outperform - MassVentures
... Ginkgo Bioworks, one of the most successful startups in the Massachusetts ecosystem over the last 10 years. At the seed stage of venture investing, you ...
Ginkgo Bioworks Secures $45 Million to Support Next Stage of Growth. Ginkgo ... Massachusetts to assist Massachusetts companies that have … Continue reading.
Ginkgo Bioworks scraps Seaport expansion plans amid struggles
Embattled Boston-based cell production company Ginkgo Bioworks is curtailing its expansion plans in the city's Seaport District just a few weeks ...
MassVentures Report Highlights START Success
In 2012, MassVentures launched the SBIR Targeted Technologies program- START- to ensure growing Massachusetts ... “MassVentures helps companies like Ginkgo ...
2021 START Winners Reshape the Present and Future of Life ...
Boston Globe tech columnist Scott Kirsner recently named Boston ... Massachusetts' life science and deep tech ... MassVentures helped Ginkgo Bioworks at the ...
MassVentures doubles down on diverse founders with $30 million ...
Among its best-known investments has been Ginkgo Bioworks, a Boston synthetic biology company that went public last year. MassVentures was one ...
Deep tech: The next frontier of the Mass. innovation ecosystem
Enter Ginkgo Bioworks, Boston's biotechnology giant, whose technology is helping speed up vaccine production at companies like Moderna.
MassVentures OPMO FY2020 Report - Mass.gov
... Ginkgo. Bioworks - Awarded $40MM NIH RADx-ATP Contract to Expand High Throughput SARS-CoV-2 TestingKytopen. - helping with the COVID-19 response through rapid ...
MassVentures is a venture capital firm focused on fueling the Massachusetts innovation economy by funding early-stage, high-growth Massachusetts startups as ...
2018 MassVentures START program kick off!
Join the growing ranks of successful Massachusetts companies who are a part of the START program. Past winners include Ginkgo Bioworks ...
MassVentures Fiscal 2015 Annual Report - Mass.gov
Boston. Debt Investment to Fund Operations. $ 133,500. Ginkgo Bioworks, Inc.*. Boston. Equity Investment to Fund Operations. $ 150,000. Jebbit, Inc*. Boston.
Our 2021 Performance - MassVentures
... Ginkgo Bioworks went public in October, trading shares under the ticker symbol DNA. MassVentures has accompanied Ginkgo's ... Massachusetts Lowell and brings a ...
Ginkgo Bioworks Expands Commitment to Entire Marcus Partners ...
BOSTON – Marcus Partners announced that Ginkgo Bioworks (NYSE: DNA), the organism company, will occupy 100% of the firm's new life science ...
Ginkgo Bioworks Expands Commitment at Marcus Partners Life ...
Flynn Marine Park (RLFMP) in the South Boston Waterfront neighborhood. Previously announced as the anchor tenant, Ginkgo Bioworks is now ...
MassVentures - Fueling Early Stage Companies in Massachusetts ...
MassVentures is a venture capital firm focused on fueling the Massachusetts innovation economy by funding early-stage, high-growth Massachusetts startups as ...
The Top 11 VC-Funded Biotechs in Massachusetts - BioSpace
Vedanta Biosciences, based in Cambridge, Mass., focuses on developing a class of therapeutics that modulate the interaction between the human ...
MassVentures investor portfolio, rounds & team | Dealroom.co
Venture capital firm focused on supporting massachusetts-based startups to prosper in their businesses. Launch date. 1978. Employees.